News
Investor's Business Daily on MSN24m
Why GeneDx, An IBD 50 Stock, Has Skyrocketed 34% Over The Past Two DaysBy 2029, the company is expected to report more than $670 million in sales, according to FactSet.IBD 50 Biotech StockGeneDx stock has largely trended sideways over recent months in the wake of a first ...
Hims & Hers fell by 34.63 percent on Monday to close at $41.98 apiece after Novo Nordisk terminated its marketing partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback